Asceneuron's Seed VC Round

Asceneuron raised a round of funding on October 02, 2012. Investors include Merck Ventures.

Asceneuron researches and develops oral small molecule therapeutics targeting tauopathies for treating progressive supranuclear palsy (PSP), other related neurodegenerative diseases and Alzheimer's di…

Articles about Asceneuron's Seed VC Round: